Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients

BJU International

Volumn 113, Issue 5 B, 2014, Pages

  Thompson, R Houston ^a   Boorjian, Stephen A ^a   Kim, Simon P ^b   Cheville, John C ^a   Thapa, Prabin ^a   Tarrel, Robert ^a   Dronca, Roxana ^a   Costello, Brian ^a   Frank, Igor ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; Cystectomy; Glomerular filtration rate; Urinary bladder neoplasms

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYDRONEPHROSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY DIVERSION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BLADDER TUMOR; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY;

CISPLATIN; CYSTECTOMY; GLOMERULAR FILTRATION RATE; URINARY BLADDER NEOPLASMS;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYSTECTOMY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84902358201     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12274     Document Type: Article

References (13)

1. Sternberg CN, Donat SM, Bellmunt J et al. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 2007; 69: 62-79 (Pubitemid 46186484)
2. Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.N Engl J Med 2003; 349: 859-66 (Pubitemid 37025405)
3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-6
4. Montie JE, Clark PE, Eisenberger MA et al. Bladder cancer. J Natl Compr Canc Netw 2009; 7: 8-39
5. Galsky MD, Hahn NM, Rosenberg J et al. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. Lancet Oncol 2011; 12: 211-4
6. von der Maase H, Hansen SW, Roberts JT et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18: 3068-77
7. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-4
8. Matsushita K, Mahmoodi BK, Woodward M et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941-51
9. Mertens LS, Meijer RP, Kerst JM et al. Carboplatin based induction chemotherapy for nonorgan confined bladder cancer - a reasonable alternative for cisplatin unfit patients? J Urol 2012; 188: 1108-13
10. Dash A, Galsky MD, Vickers AJ et al. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer 2006; 107: 506-13 (Pubitemid 44107210)
11. Canter D, Viterbo R, Kutikov A et al. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology 2011; 77: 160-5
12. Raj GV, Iasonos A, Herr H, Donat SM. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. J Clin Oncol 2006; 24: 3095-100 (Pubitemid 46638946)
13. Rinnab L, Straub M, Hautmann RE, Braendle E. Postoperative resorptive and excretory capacity of the ileal neobladder. BJU Int 2005; 95: 1289-92 (Pubitemid 40799448)